Always Targets Heavy Periods with New Pad and Fibroid Foundation Pact

CINCINNATI, OH – March 05, 2026 – In a move that merges product innovation with public health advocacy, menstrual care leader Always has announced a sponsored partnership with The Fibroid Foundation. Timed ahead of International Women's Day, the collaboration aims to confront the widespread yet often-stigmatized issue of heavy menstrual bleeding (HMB), a condition that disrupts the lives of millions of women. The initiative coincides with the launch of the new Always Maxi Size 6, the brand's most absorbent pad, engineered specifically for severe menstrual flow.

This partnership signals a strategic effort to move beyond product sales and engage directly with a significant women's health challenge. By joining forces, the corporate giant and the patient-led nonprofit hope to foster open dialogue, improve health literacy, and empower women to seek the care they need for a condition too often endured in silence.

A Common Condition Hidden in Plain Sight

Heavy menstrual bleeding is more than an inconvenience; it is a clinically defined condition characterized by blood loss excessive enough to interfere with a person's physical, social, and emotional quality of life. Symptoms include bleeding for more than seven days, needing to change a pad or tampon every one to two hours, and passing blood clots larger than a quarter. A leading cause of HMB is uterine fibroids—benign tumors that grow in or on the uterus. According to medical studies, they are extraordinarily common, affecting an estimated 70-80% of women by the age of 50.

While many women with fibroids have no symptoms, those who do can face a debilitating array of issues. Beyond excessive bleeding that can lead to anemia and chronic fatigue, symptoms may include severe pelvic pain, urinary problems, bloating, and infertility. The impact on daily life is profound, with research showing that women with symptomatic fibroids report a lower quality of life comparable to those with chronic conditions like heart disease or diabetes. Many women report missing work, avoiding social engagements, and experiencing heightened levels of anxiety and depression.

This is a reality Sateria Venable, Founder of The Fibroid Foundation, knows intimately. Her organization was born from her own difficult journey, which included years of heavy bleeding and three surgeries while trying to manage a demanding career. Her experience highlights a common pattern where women may deprioritize their health or dismiss severe symptoms as normal.

"Every woman living with fibroids and heavy menstrual bleeding has a story that deserves to be heard," said Venable in the official announcement. "We're excited to work together with Always to shine a brighter light on an issue that affects millions of women... and to help women seek the information and care they need to better manage their symptoms."

Bridging Advocacy and Commercial Innovation

The collaboration between a global brand like Always, a subsidiary of Procter & Gamble, and a dedicated advocacy group like The Fibroid Foundation represents a growing trend in corporate social responsibility. It aligns with Always' long-standing brand messaging focused on female empowerment, most famously demonstrated by its groundbreaking '#LikeAGirl' campaign, which sought to redefine a common insult into a statement of confidence.

By tackling the taboo surrounding heavy periods and fibroids, the brand reinforces its commitment to women's well-being. The partnership is structured to leverage the strengths of both organizations: Always brings its massive market reach and product development capabilities, while The Fibroid Foundation provides credibility, patient-centered insights, and educational resources. While the foundation maintains a policy of not endorsing specific products, its collaboration on the awareness campaign lends authenticity to the broader health message.

This initiative is not just altruistic; it is rooted in consumer research and market needs. "Our research showed that heavy menstrual bleeding can significantly disrupt routines and overall well-being, diminishing a woman's quality of life," stated Alexzandra Spatholt, Lead Scientist at Always. "This crucial insight informed and inspired the development of Always' newest and largest Maxi, Size 6."

An Unmet Need for Better Protection

For women experiencing HMB, finding adequate menstrual products is a constant struggle. Standard 'heavy' or 'overnight' pads can fail to manage extreme flow or the passage of blood clots, leading to frequent leaks, discomfort, and a persistent fear that undermines confidence. This creates a significant, underserved segment of the consumer market.

The introduction of the Always Maxi Size 6 pad is a direct response to this unmet need. Described as the brand's most absorbent maxi pad, it features new leak-guard cuffs specifically designed for 'clot defense'—a feature that directly addresses one of the most challenging aspects of HMB. By engineering a product for the most severe cases, Always is providing a practical tool that could tangibly improve the daily lives of those who have long felt ignored by the market.

This focus on a niche but critical need allows the brand to differentiate itself from competitors and build loyalty with a demographic that desperately requires reliable solutions. It transforms the conversation from simple absorbency to a more holistic understanding of the challenges posed by conditions like uterine fibroids.

Breaking the Silence and Seeking Care

The ultimate goal of the partnership extends far beyond the product itself. It is a campaign to destigmatize the conversation around menstrual health and encourage women to become advocates for their own bodies. The journey to a diagnosis for fibroids is often fraught with delay and dismissal. Symptoms can be misdiagnosed as other conditions like endometriosis or even irritable bowel syndrome, causing women to suffer for years without proper treatment.

Empowering women with information is a critical first step. Once diagnosed, a range of effective treatment options for fibroids exists, from non-hormonal medications and hormone therapies to minimally invasive procedures like Uterine Artery Embolization (UAE) and surgical options such as myomectomy (fibroid removal) or hysterectomy. The key is an early and accurate diagnosis, which can only happen when women feel comfortable discussing their symptoms openly with healthcare providers.

By bringing the topic of heavy menstrual bleeding out of the shadows, Always and The Fibroid Foundation aim to normalize the conversation and shorten the path from symptom onset to effective medical care. The joint effort provides educational resources through their respective websites, offering a starting point for women who suspect their periods are not 'normal.' This dual approach—providing both innovative physical products and critical educational resources—aims to equip women with the tools and the confidence to manage their health proactively.